2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies
RSC Medicinal Chemistry · 2026 · 17 (1) · 317-342
DOI: 10.1039/d5md00628g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Wesam S Qayed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University 71526 Assiut Egypt Wesam.qayed@aun.edu.eg. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Design and evaluation of 2-oxoindolin/thiosemicarbazone–thiazoline hybrids as dual antidiabetic and anti-alzheimer agents.
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University 71526 Assiut Egypt Wesam.qayed@aun.edu.eg.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University 34093 Fatih İstanbul Türkiye.
- Department of Biotechnology, Faculty of Science, Bartin University 74110 Bartin Türkiye.
ORCID-Profile: Wesam S Qayed, Mostafa A Hassan, Parham Taslimi, Tarek Aboul-Fadl
Zitieren
APA
Qayed, W. S., Hassan, M. A., Şenol, H., Taslimi, P., & Aboul-Fadl, T. (2026). 2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies. RSC Medicinal Chemistry, 17(1), 317-342. https://doi.org/10.1039/d5md00628g
Vancouver
Qayed WS, Hassan MA, Şenol H, Taslimi P, Aboul-Fadl T. 2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies. RSC Medicinal Chemistry. 2026;17(1):317-342. doi:10.1039/d5md00628g
BibTeX
@article{Qayed2026,
author = {Qayed, Wesam S and Hassan, Mostafa A and Şenol, Halil and Taslimi, Parham and Aboul-Fadl, Tarek},
title = {2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies},
journal = {RSC Medicinal Chemistry},
year = {2026},
volume = {17},
number = {1},
pages = {317--342},
doi = {10.1039/d5md00628g}
}
EUVIMED